21-U.S.C.-355D

§355D – Internal Committee For Review of Pediatric Plans, Assessments, Deferrals, Deferral Extensions, and Waivers

Pathway

Title 21 > Chapter 9 > Subchapter V > Part A > Section 355d

Details

• Reference: Section 355d
• Legend: §355D – Internal Committee For Review of Pediatric Plans, Assessments, Deferrals, Deferral Extensions, and Waivers
• USCode Year: 2013

Provision Content

The Secretary shall establish an internal committee within the Food and Drug Administration to carry out the activities as described in sections 355a(f) and 355c(f) of this title. Such internal committee shall include employees of the Food and Drug Administration, with expertise in pediatrics (including representation from the Office of Pediatric Therapeutics), biopharmacology, statistics, chemistry, legal issues, pediatric ethics, neonatology, and the appropriate expertise pertaining to the pediatric product under review, such as expertise in child and adolescent psychiatry, and other individuals designated by the Secretary.

(June 25, 1938, ch. 675, §505C, as added Pub. L. 110–85, title IV, §403, Sept. 27, 2007, 121 Stat. 875; amended Pub. L. 112–144, title V, §509(c), July 9, 2012, 126 Stat. 1049.)

Amendments

2012—Pub. L. 112–144 inserted deferral extensions, after deferrals, in section catchline and neonatology, after pediatric ethics, in text.

U.S. Encyclopedia of Law Coverage

Topic Map

• Browse the Topic Map in relation with Title 21 (Food And Drugs) guided by subject interests.